JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.

JMCP 欢迎在美国境外进行与我们的读者相关的研究。我们的读者主要关注基于大量人群的证据而设计处方集覆盖、健康福利设计和药物计划的政策。在美国境外进行的药剂师干预研究（这些研究已在美国境内进行了广泛研究）以及在美国境外非管理式医疗环境（例如医院或社区药房）中进行的小样本研究通常不会引起我们的读者的兴趣。但是，在大量人群中评估的健康结果和成本研究为处方集覆盖、健康福利设计和药物计划提供了证据，这对 JMCP 的读者来说很有吸引力。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映Health Professions-Pharmacy领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.3，平均审稿速度为 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。